Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 3 × Chemotherapy-induced Neutropenia × NPI 2358 × Clear all

Phase

Phase 3 2 Phase 2 2

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Chemotherapy-induced Neutropenia 2 Carcinoma, Non-Small-Cell Lung 1

Interventions

pegfilgrastim 3 NPI 2358 2 Granulocyte Colony-Stimulating Factor 2 Doxorubicin 2 Docetaxel 2 balugrastim 1 Drug Therapy 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03102606 2024-08-29

Protective-1

BeyondSpring Pharmaceuticals Inc.

Phase 3 Completed

105 enrolled 16 charts

Chemotherapy-induced Neutropenia

NCT03294577 2021-01-15

Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia

BeyondSpring Pharmaceuticals Inc.

Phase 3 Unknown

Chemotherapy-induced Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡